SCHEMBL13453362

SCHEMBL13453362

Cc1cc(NC(=O)C(Sc2cccc[n+]2[O-])c2c(C)c(C)cc(C)c2C)cc(C)c1C

nearest known ligand 0.61

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ PCTP Q9UKL6 11/20 0.61
▸ STARD10 Q9Y365 3/20 0.59
▸ STARD7 Q9NQZ5 1/20 0.59
▸ ALDH1A1 P00352 5/20 0.47
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ LMNA P02545 3/20 0.45
▸ POLB P06746 1/20 0.45
▸ GAA P10253 1/20 0.43
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ KMT2A Q03164 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13453359 0.82 PCTP (0.53) PCTPSTARD10STARD7ALDH1A1SMN1; SMN2
SCHEMBL1235095 0.76 PCTP (1.00) PCTPSTARD10STARD7ALDH1A1SMN1; SMN2
SCHEMBL1233503 0.74 PCTP (1.00) PCTPSTARD10STARD7ALDH1A1SMN1; SMN2
SCHEMBL1234489 0.73 PCTP (1.00) PCTPSTARD10STARD7ALDH1A1SMN1; SMN2
SCHEMBL1234495 0.73 PCTP (1.00) PCTPSTARD10STARD7ALDH1A1SMN1; SMN2
SCHEMBL13276035 0.72 PCTP (1.00) PCTPSTARD10STARD7ALDH1A1SMN1; SMN2
SCHEMBL1234605 0.71 PCTP (0.79) PCTPSTARD10STARD7ALDH1A1SMN1; SMN2
SCHEMBL1234494 0.70 PCTP (0.78) PCTPSTARD10STARD7ALDH1A1SMN1; SMN2
SCHEMBL1235198 0.70 PCTP (1.00) PCTPSTARD10STARD7ALDH1A1SMN1; SMN2
SCHEMBL1235185 0.69 PCTP (1.00) PCTPSTARD10STARD7ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9556129-B2 Phosphatidylcholine transfer protein inhibitors THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2017-01-31 — — US disclosed
US-20150336902-A1 Phosphatidylcholine Transfer Protein Inhibitors THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 2015-11-26 — — US disclosed
US-9126938-B2 Phosphatidylcholine transfer protein inhibitors THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2015-09-08 — — US disclosed
US-20120264756-A1 Phosphatidylcholine Transfer Protein Inhibitors THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2012-10-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264756-A1 Phosphatidylcholine Transfer Protein Inhibitors PCTP, LCAT, CETP PCTP 1/4885STARD10 1028/4885STARD7 117/4885
US-20150336902-A1 Phosphatidylcholine Transfer Protein Inhibitors PCTP, LCAT, CETP PCTP 1/4885STARD10 1028/4885STARD7 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback